Jisoon Hwang
Family · Baltimore, MDNPI 1407108319
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,523 and has fallen 73.0% since, to $411 in 2025. Among family clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 40 payments — averaging $107.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Neurocrine Biosciences, Inc.$333
- AbbVie$235
- EMD Serono, Inc.$228
- Teva Pharmaceuticals USA, Inc.$226
- Boehringer Ingelheim$224
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,298100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 10 | $1,028 |
| Neurocrine Biosciences, Inc. | 3 | $333 |
| AbbVie | 2 | $235 |
| EMD Serono, Inc. | 2 | $228 |
| Teva Pharmaceuticals USA, Inc. | 2 | $226 |
| Boehringer Ingelheim | 1 | $224 |
| Novo Nordisk | 2 | $215 |
| Boston Scientific | 1 | $138 |
| Amgen | 1 | $125 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $122 |
| Aimmune Therapeutics, Inc. | 1 | $120 |
| Novartis | 1 | $118 |
| Amarin Pharma, Inc. | 1 | $117 |
| Jazz Pharmaceuticals Inc. | 1 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $115 |
| Biogen | 1 | $105 |
| Axsome Therapeutics, Inc. | 1 | $105 |
| Corcept Therapeutics | 1 | $102 |
| Idorsia Pharmaceuticals US Inc | 1 | $101 |
| Bristol Myers Squibb | 1 | $97 |
| Insmed, Inc. | 1 | $93 |
| Sanofi-aventis U.S. LLC | 1 | $90 |
| Sage Therapeutics, LLC | 1 | $77 |
| Recordati_rare_diseases_inc. | 1 | $55 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,298 in reported general payments places this provider in the 90th percentile of 2,843 family providers in Maryland.
Other family in Baltimore
- Hazel Jones-ParkerBaltimore$96K
- Brittany WilsonBaltimore$88K
- Lisa ScottiBaltimore$35K
- Leah HartBaltimore$32K
- Jinae ArneklevBaltimore$24K
- Valerie OwenBaltimore$12K
- Eldho ChackoBaltimore$12K
- Melonie OwusuBaltimore$10K
- Amanda NevinBaltimore$9K
- Suryamol ChackoBaltimore$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.